Literature DB >> 3064593

Influence of sublingual captopril on plasma catecholamine levels during hypertensive emergencies and cold immersion.

J J Polonia1, A Monteiro, A Esteves, M E Cunha, M L Santos, J Coutinho, J L Coelho, F A Brandao, M Cerqueira-Gomes.   

Abstract

Experimental evidence of captopril-induced inhibition of sympathetic activity, mediated by decrease in angiotensin II production, is presented. The blood pressure, plasma catecholamine, plasma renin activity, and plasma aldosterone responses to a single dose of sublingual captopril in 23 patients with hypertensive emergencies were evaluated. The major correlation found was between the captopril-induced decrease in blood pressure and the decrease in plasma norepinephrine levels (r = 0.57, p less than 0.01). In another 11 hypertensive patients with normal or high renin levels, captopril lowered by 65 percent the increase in plasma norepinephrine induced by cold immersion of the forearm. In both circumstances, plasma renin and aldosterone levels changed in accordance with the expected inhibition of angiotensin converting enzyme activity. These data suggest that, in selected circumstances in hypertensive patients, captopril exhibits a depressive influence on sympathetic activity along with the inhibition of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064593     DOI: 10.1016/0002-9343(88)90223-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

1.  The effect of captopril on peripheral hemodynamics in patients with essential hypertension: comparison between oral and sublingual administration.

Authors:  C Longhini; L Ansani; G Musacci; D Mele; M Vaccari; E Baracca; P Sgobino
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Sublingual captopril in hypertensive urgencies.

Authors:  A Misra; P Jain; R B Reddy
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.